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Dear Editor, 
Cardiac resynchronization therapy (CRT) has been shown to result in improvement in left 
ventricular (LV) function. However, the effects of CRT on right ventricular (RV) 
function have not been well described.  In this study, we evaluated the effects of CRT on 
RV function. 
 
A systematic review of the literature was performed according to the PRISMA (Preferred 
Reporting Items for Systematic reviews and Meta-Analyses) statement [1]. We 
systematically searched PubMed, CINAHL, Cochran CENTRAL, Scopus and Web of 
Science databases for all studies that reported parameters of RV function before and after 
CRT implantation. All relevant combinations of following keywords related to cardiac 
resynchronization therapy, RV function, tricuspid annular plane systolic excursion 
(TAPSE), RV diameters, RV short axis diameter, RV long axis diameter, RV fractional 
area change (FAC) were included for database search. The search was conducted from 
the inception of these databases to October 31, 2015. Studies were included if they met 
the following criteria: 1) human studies with participants of any age requiring CRT for 
any indication, 2) reported tricuspid annular plane systolic excursion (TAPSE) or RV 
basal strain or RV long axis diameter or RV short axis diameter or RV fractional area 
change (FAC) as absolute number (with standard deviations) before and after CRT. 
Two independent reviewers (AS, SG) screened the titles and abstracts for relevance. Any 
disagreements in data extraction were discussed until consensus was reached.  
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Mix 2.0 Pro (Biostat XL) software was used to analyze the data. A random-effects model 
with inverse variance weighting was used to calculate pooled mean difference in RV 
measure and corresponding confidence interval. Heterogeneity between studies was 
assessed using Cochrane’s Q test and I2 statistic, which denotes the percentage of total 
variation across studies that is a result of heterogeneity rather than chance. Heterogeneity 
was considered significant if the p value was less than 0.05. Publication bias was assessed 
by Begg’s test and Egger’s regression test.  The influence of individual studies was 
examined by removing each study at a time to assess the degree to which meta-analysis 
estimate depends on a particular study (exclusion sensitivity analysis).  
 
A total of 13 studies were identified (n=1541) [2-14] (Supplementary figure 1). Baseline 
characteristics of various studies have been summarized in Supplemental table 1 and 2. 
Publication bias was not detected by Begg’s and Eggers’ regression test for any of RV 
measures. Our results suggest that CRT led to improvements in RV size and function that 
were consistent across the different measures of RV function. There was a statistically 
significant increase in TAPSE (Figure 1), RV basal strain (Supplementary figure 2) and 
RV fractional area change with CRT (Supplementary figure 3).  Moreover, CRT led to 
significant improvements in RV dimensions as determined by RV long axis 
(Supplementary figure 4) and short axis diameters (Supplementary figure 5).  
 
To our knowledge, this is the first meta-analysis to evaluate the impact of CRT therapy 
on RV size and function. We reported various parameters of RV function in 1541 patients 
from 13 studies, with a mean follow- up period of almost 9months. Most of the studies 
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included in our study have used TAPSE as a measure of RV function, which relatively 
simple echocardiographic measure, which represents RV longitudinal function, which has 
shown to have a good correlation with more precise measures of RV systolic function, 
including radionuclide estimation of RV ejection fraction (RVEF) [15]. The exact 
mechanism of how CRT improves the RV function is not clear, but the most plausible 
explanation is that CRT leads to favorable LV remodeling, which causes decline in LV 
volumes and improvements in LV systolic function, which might improve the RV filling 
and RV systolic function [16]. CRT therapy reduces LV end diastolic pressures, mitral 
regurgitation and pulmonary artery pressures, which ultimately leads to decreased RV 
afterload and improvements in RV contractility [17, 18]. The RV shares oblique fibers 
with the LV within the interventricular septum, which facilitates the augmentation of RV 
contraction with LV systolic contraction [18]. With declining LV function, there is re-
orientation of oblique septal fibers to more transverse position as the LV become more 
spherical secondary to volume overload. This dramatically reduces the mechanical 
advantage of RV contractility by these oblique fibers [18]. CRT induces LV remodeling 
and thereby could lead to repositioning of these fibers and lead to improvements in RV 
function.  
 
There are several potential limitations in our meta-analysis. First, studies used in our 
analysis did not use advanced cardiac imaging modalities to evaluate RV function. The 
RV has a complex geometry and is volume dependent and affected by preloading 
conditions, which pose a challenge in accurately determining the RV function [15]. Since 
echocardiography is inexpensive and readily available, it is the most heavily utilized 
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modality to measure RV function. Since one echocardiographic measure might not 
accurately represent true RV function, we used multiple parameters of RV function. Our 
results show improvement across all parameters of RV function, including TAPSE and 
FAC, which have been reported to correlate well with measure of RV function obtained 
by cardiac MRI. Second, as mentioned above, we could not include a few studies in our 
analysis, as these studies did not report data in terms of absolute number for RV 
parameters before and after CRT therapy. One of these studies also showed improvement 
in RV function with CRT, which is in consensus with our results [19]; another study, 
however, reported no statistically significant improvement in RV function with CRT 
[20]. However, this study could have missed the subtle changes in RV function, as it did 
not report newer echocardiographic RV function parameters such as RV strain, which 
have been evaluated in our study [20]. Third, there was significant heterogeneity in 
several parameters of RV function in our study. Thus, precluding a robust conclusion. 
Large-scale prospective studies will be helpful in further evaluating the response of CRT 
on RV function. Fourth, it is assumed that patients enrolled in the studies included in our 
analysis would have had optimal medical management. However, it cannot be claimed 
conclusively since medical optimization data was missing in few studies included in the 
meta-analysis. 
 
In conclusion, our results suggest that CRT led to improvements in RV size and function 
as measured by TAPSE, RV FAC, RV basal strain, RV long axis and short axis 
diameters. Future studies should assess the impact of these changes on symptoms, quality 
of life and major HF morbidity and mortality. 
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Figure 1. Forest plot for tricuspid annular plane systolic excursion with cardiac 
resynchronization therapy 
 
